目前治疗胶质母细胞瘤的疗法直接采用抑制另一种细胞受体，即上皮生长因子受体(EGFR)。
Current therapies to treat glioblastomas are directed toward blocking the activity of another cellular receptor called epithelial growth factor receptor (EGFR).
目前治疗胶质母细胞瘤的疗法直接采用抑制另一种细胞受体，即上皮生长因子受体(EGFR)。
Current therapies to treat glioblastomas are directed toward blocking the activity of another cellular receptor called epithelial growth factor receptor (EGFR).
应用推荐